tial medium (MEM) and dispersed by mincing the organs with iris scissors. This step was followed by successive aspiration with syringe and needles progressively from a 19 gauge needle to a 23 gauge and finally a 27 gauge. Cells were suspended in culture medium after a single wash.
Anti-CBA/Y Brain Antiserum.--Bralns of CBA/J were removed, homogenized, and injected into Dutch Belt rabbits for production of anti-BA0 according to protocol used by Golub (13) . The cytotoxic titer of the antiserum used for all the experiments reported herein was 1 : 128.
Absorption of Antisera and Complement.--The antisera and normal rabbit serum (C) were absorbed with CBA/J mouse erythrocytes, liver, and agarose (14) .
Cytotoxic Tests.--O.05 ml of absorbed rabbit anti-CBA brain diluted 1:10 was added to 0.l ml of cells at a density of 2 X 107/ml. 0.05 ml of absorbed C was added next and the mixture was incubated 1 h at 37°C. Cytotoxic potency of the antisera was determined by trypan blue exclusion. The cytotoxic index (C.I.) was calculated from the following formula:
% dead with antiserum --% dead with normal rabbit serum C.I.= 100 --% dead with normal rabbit serum A killing of 100% of the cells would give a C.I. of 1.0. Absorptions of antibrain serum with lipid fractions (prepared as discussed below) were incubated for 1 h before incubation with thymocytes and complement.
Lipid Extra~tion.--CBA/J brain or thymocyte gangliosides were prepared by homogenization of 8.3 g of CBA/J brains or 2.4 X 109 CBA/J thymocytes with chloroform-methannl 2:1 (vol/vol) in a Waring blender (Waxing Products Div., Dynamics Corp. of America, New Hartford, Conn.) as described previously (15) . The extract was submitted to a Folch partition (16), the ganglioside-rich upper layer was dialyzed and the nondialyzable material was evaporated to dryness in vacuo and further purified by thin-layer chromatography. All solvents were redistilled before use. Further details of isolation and separation procedures are given in another report (15) .
Thin-Layer Chromatography,--Dialyzed upper phases were evaporated to dryness in vacuo and applied to a thin-layer plate of 0.25 mm of Silica Gel G (Analtech, Inc., Wilmington, Del.). The plates were developed with chloroform-methanol-2.5 N ammonium hydroxide 60:40:9 (vol/vol/vol) in unlined thin-layer tanks. Ganglioside-containing areas were visualized by spraying with resorcinol solution (17) . Areas to be used for immunological or chemical tests were visualized with iodine vapors, and bands were scraped into disposable pipettes with glass wool plugs which were eluted with 10-15 ml of chloroform-methanol-water 10:10:3 (vol/ vol/vol). Blueprints were made of resorcinol-or iodine-stained plates using diazo paper (18) . Sialic acid was determined by the modified method (19) of Svennerholm.
Auxiliary Lipids.--Mixed upper-phase (ganglioside-rich) lipids and purified lipids were formulated with cholesterol-lecithin (auxiliary lipid) mixtures. The glycolipid (1-4/~g) and the auxiliary lipids (5 #g cholesterol and 5 #g lecithin [Supelco, Inc., Bellefonte, Pa.]) were mixed in a small volume of chloroform-methanol 1:1. The solvents were evaporated under nitrogen and 50 #1 of water was added, followed by sonication in an ultrasonic cleaner (Mettler Electronics Corp., Anaheim, Calif.) for 30 s, and heating at 100°C for 1 rain. The emulsion was made isotonic with 50/zl of 1.7% NaCI and mixed on a vortex mixer.
RESULTS
Total lipid extracts prepared from CBA/J mouse thya~qocytes were partitioned between chloroform-methanol-water two-phase systems. The lower phase (neutral lipids) and the upper phase (ganglioside-rich) were tested for inhibitory activity (Table I) . Lower-phase lipids demonstrated little or no Upper-phase lipids were separated by thin-layer chromatography ( Fig. 1 ) and isolated as described in the Materials and Methods. Individual mouse brain (MB) gangliosides were identified by comparison of their RI and pattern to human brain gangliosides (HB) of known structure (20) . Thymocyte upperphase lipids or gangliosides were compared to mouse and human brain gangliosides by thin-layer Rf. Strong resorcinol reactions were obtained with the brain gangliosides, but the thymocyte lipids gave only weak reactions because of the small amount of material present.
The isolated lipids were formulated with auxiliary lipids and tested for ability to inhibit cytotoxicity of anti-BA 0 antiserum (Table II) . Area E (Fig. 1) of the thymocyte lipids (TC) was capable of complete inhibition (C.I. = 0.01). The only other thymocyte lipid demonstrating slight activity was the adjacent area F (C.I. = 0.70), and this probably represents overlap with area E. Comparable inhibition was obtained from upper-phase lipids extracted from 4.8 X l0 T thymocytes, C.I. = 0.01 (Table I ) and isolated lipid from 5.9 X 107 thymocytes, C.I. = 0.01 (E , Table II) . These results indicate a high yield of active BA0 antigen during the purification steps.
The most active fraction among the brain gangliosides had a thin-layer RI Letters refer to thyrnocyte lipids in Fig. 1 (extracted 5.9 X 10 7 cells). § Micrograms of ganglioside added is based on the number of micrograms of sialic acid in the isolated lipid. The amounts reflect the relative proportions of the gangliosides isolated.
identical to Grab ganglioside and with the active thymocyte lipid. Inhibitory activity associated with GT1 and to a much lesser extent with Gm was probably due to overlap with the active Grab fraction. When the gangliosides were further purified b y thin-layer chromatography only the C~xb fraction was inhibitory. Furthermore, the amount of Grab used in this assay was much more than the a m o u n t necessary to give complete inhibition, as little as 0.39 #g of G~lb gave a C.I. of 0.04.
Further support for the glycosphingolipid nature of BA~ antigen was the finding that auxiliary lipids were essential for activity. No activity was observed when 1.19 #g of Grab ganglioside was formulated without auxiliary lipids (C.I. = 0.84). When as little as 1 #g each of cholesterol and lecithin was added to the preparation complete inhibition was observed (C.I. = 0.07).
The possibility that the glycolipid antigen was interacting with complement was eliminated by absorbing the antiserum with the antigen, followed by a period of incubation with thymocytes. The thymocytes were then washed to remove glycolipid antigen and complement was added. The same degree of lysis was observed in this case as in experiments where lysis was performed as described in the Materials and Methods.
DISCUSSION
This report describes the partial characterization of an antigen which has been isolated from mouse thymocytes and brain and which is capable of inhibiting the cytotoxicity of anti-BA0 antiserum. The antigen is extractable into lipid solvents and is located in the upper-aqueous phase of a Folch partition (16). The antigen is water "soluble," requires auxiliary lipids for immunological activity, and migrates, by thin-layer chromatography with GDlb ganglioside.
These data are consistent with the proposal that BA0 antigen is GDlb ganglioside.
Reif and Allen (3) reported that 0-C3HeB/Fe isoanfigen of thymus was nondialyzable and could not be recovered in active form after treatment with lipid solvents, such as chloroform-methanol 2 : 1 (vol/vol). The active ganglioside reported here is nondialyzable in spite of its low tool wt (about 2,000) because it exists in solution in large aggregates or micelles (7) .
Antisera to bovine brain have been found to have antibodies specific for gangliosides (12) and antisera to bovine brain gangliosides were found to contain antibodies for Gi)lb and GM1 (11, 12) . From this information we conclude that there are anti-GDlb antibodies in the rabbit antimouse brain antisera and that this ganglioside, exposed on the surface of thymocytes and T lymphocytes, is responsible for the cytotoxicity of the anti-BA0 antisera.
Atwell et al. (21) have reported that 0-antigen is a protein with a mol wt of about 60,000 daltons. Using a similar system of immunoprecipitation of radioiodinated cell-surface proteins, we were unable to precipitate significant protein material (assessed by SDS-gel electrophoresis) using rabbit anti-CBA brain antiserum. The antigenic activity specified by AKlZ anti-e C3H antiserum, on the other hand, may be different from the antigen activity specified by rabbit anti-CBA brain antiserum. The difference, if any, remains to be determined by examining the specificity of AKR anti-0 C3H antiserum.
Addendum: Vitetta et al. (22) have recently presented evidence that the 0-antigen (or Thy 1) of murine thymocytes is a glycolipid.
